Company intelligence / Profile preview

Eyekare Kilitch

Mumbai, Maharashtra, India

Ownership: Private
Employees: ~566
Development stage: Other

Overview

Eyekare Kilitch markets a broad portfolio of ophthalmic drugs and devices including preservative-free eye drops, gels, and injection kits, leveraging patented delivery systems to address unmet needs in dry eye, glaucoma, and retinal disease. The products are manufactured in USFDA and UKMHRA-compliant facilities; several packaging and delivery innovations are first-in-India and have approval for use in major markets.

Therapeutic areas: Ophthalmology
Modalities: Small moleculeBiologicDevice
Industry: Biotech

Drug pipeline

4 assets

TRAVOPROSTIN

Unknown

3 more assets in the full pipeline.

Request access →

Partnerships

Novelia (France) – packaging technology partner3K® System (Germany) – drug/device delivery technology partner

Beyond the preview

Go deeper on Eyekare Kilitch.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eyekare Kilitch.

Explore the full profile